Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heavy metal containing doai
Reexamination Certificate
2006-04-17
2009-08-04
Gonzalez, Porfirio Nazario (Department: 1621)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heavy metal containing doai
C514S359000, C546S002000, C548S101000, C556S137000
Reexamination Certificate
active
07569606
ABSTRACT:
Disclosed herein are novel platinum-based complexes possessing one nitrile substituent group (mononitrile) covalently-bonded to the platinum, one or more nitrogen donor ligands capable of forming hydrogen bonds with the bases in DNA or RNA and leaving groups (i.e., L1and L2)which can be hydrolyzed iii vivo to active species, which can then form coordinate adducts with DNA or RNA at the Guanine or Adenine bases thereof. Also disclosed herein are the reaction schemes for the synthesis of said platinum complexes, as well as methods of treatment of various types of cancer by the administration of a pharmaceutically-effective dose of said novel platinum complexes.
REFERENCES:
Kharitonov et al., Doklady Akademii Nauk SSSR, vol. 141, pp. 645-648 (1961).
Uchiyama, et al., The Isolation, “Characterization, and Isomerization of cis- and trans-Bis(benzonitrile)dichloroplatinum(II)”, Bull. Chem. Soc. Jpn., 54:181-85 (1981).
Hausheer Frederick H.
Petluru Pavankumar
Xiao Zejun
BioNumerik Pharmaceuticals, Inc.
BioNumerik Pharmaceuticals, Inc.
Gonzalez Porfirio Nazario
Whitaker Scott A.
LandOfFree
Platinum complexes with mononitrile-containing ligands does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Platinum complexes with mononitrile-containing ligands, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Platinum complexes with mononitrile-containing ligands will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4130641